Sandoz Group AG

SDZNY

$86.68

Updated: 23/09/2026, 16:13:26

Market Cap

$37.51B

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Stock valuation chart

One-year closing share-price history for SDZNY

Company Profile

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

USD

OTC

CEO: Richard Saynor

Employees: 23,000

https://www.sandoz.com

Asset Summaries

Latest generated summaries for SDZNY

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for SDZNY.

Share price: $86.68
Market cap: $37.51B
Exchange: OTC
Currency: USD
CEO: Richard Saynor
Employees: 23,000
IPO date: 04/10/2023
Beta: 0.492
Last dividend: $0.00
Day range: $86.59 – $87.07
52-week range: $55.42 – $94.15
1-day performance: 0.15%
1-year performance: 56.41%
Current drawdown (1Y): -7.93%
CIK: N/A
CUSIP: 799926100
ISIN: US7999261008
Created: 07/12/2025, 14:09:40
Last update: 23/09/2026, 16:13:26

Track Sandoz Group AG with an AI analyst

See which prediction-market events move SDZNY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to SDZNY from your Railway `news_articles` table.

3 Generic Drug Stocks to Watch as New Growth Drivers Emerge

Zacks Investment Research • STOCK • 05/06/2026, 14:50:40

SDZNY or UTHR: Which Is the Better Value Stock Right Now?

Zacks Investment Research • STOCK • 04/06/2026, 14:40:17

Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Buy: Here's What You Should Know

Zacks Investment Research • STOCK • 19/05/2026, 15:01:20

Sandoz CEO Says Size of Weight-Loss Generics Market Is Unknown

WSJ • STOCK • 08/05/2026, 11:15:00

Sandoz Group AG (SDZNY) Q1 2026 Sales/Trading Call Transcript

Seeking Alpha • STOCK • 29/04/2026, 10:31:40

All You Need to Know About Sandoz Group AG Sponsored ADR (SDZNY) Rating Upgrade to Buy

Zacks Investment Research • STOCK • 30/03/2026, 15:01:29

Sandoz Group AG (SDZNY) Q4 2025 Earnings Call Transcript

Seeking Alpha • STOCK • 25/02/2026, 08:31:30